BeneMACS Study:HeartMate 2 (HM2)Left Ventricular Assist Device (LVAD) Survival in Non Transplant Patients is Equal/Better Than Results in Medical Literature

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Heart Failure
Interventions
DEVICE

Left Ventricular Assist Device (HeartMate II)

The HM II is a high speed, electric, axial flow, rotary blood pump. The pump drains blood from the left ventricular apex via rigid inlet cannulae and ejects into the aortic root via an outflow cannula joined to the aorta with an end to side anastamosis. Power and control of the pump are delivered through a percutaneous cable from pump to the belt-worn System Controller. The System Controller will receive power from the Power Base Unit (PBU), or two battery modules that may be worn in shoulder holsters or on the belt

Trial Locations (2)

1200

Cliniques Universitaires St Luc, Brussels

3000

Leuven Gasthuisberg University Hospital, Leuven

Sponsors
All Listed Sponsors
collaborator

KU Leuven

OTHER

collaborator

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

collaborator

Interagency Registry for Mechanical Assisted Circulatory Support (INTERMACS)

UNKNOWN

collaborator

Thoratec Corporation

INDUSTRY

collaborator

Thoratec Europe Ltd

INDUSTRY

lead

Abbott Medical Devices

INDUSTRY